Crowdonomics
All companies

AnTix Holdings, Inc.

Operating

Healthcare · Blue Island, IL

Estimated pre-money ⓘ
$3.5M
As of Dec 2024 · from Reg A Offering (2024) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$1,084,199
Crowd $0 · Private $1.1M · 3 rounds since 2011
Latest share price
$0.125
Reg A Offering (2024) offering price

Financials

FY2010–FY2025 (no data for FY2015, FY2016, FY2017, FY2018, FY2019) · from SEC filings · hover any figure for its source
$0
−$567K
2013
$0
−$365K
2014
2015no data
2016no data
2017no data
2018no data
2019no data
$0
−$490K
2020
$349K
−$3.3M
2021
$1.3M
−$18.1M
2022
$1.7M
−$3.6M
2023
$1.8M
−$7.9M
2024
$1.3M
2025
RevenueNet income — beside revenue when positive, below the line when a loss

Chart shows the most recent 8 fiscal years; 3 earlier years are in the table below.

Metric
FY2010 audited
FY2011 audited
FY2012 audited
FY2013 audited
FY2014 audited
FY2020 audited
FY2021 audited
FY2022 audited
FY2023 audited
FY2024 audited
FY2025 audited
Income statement
Revenue
$762,488
$868,849
$0
$0
$0
$0
$349,143
$1,297,613
$1,724,843
$1,824,925
—
Cost of goods sold
$558,165
$506,026
$0
$0
$0
—
—
—
$0
—
—
Gross margin
27%
42%
—
—
—
—
—
—
100%
—
—
Net income
-$2,015,518
-$1,047,113
-$1,488,485
-$566,859
-$365,344
-$489,695
-$3,264,957
-$18,058,354
-$3,647,947
-$7,938,897
$1,268,903
Taxes paid
—
$0
$0
$0
$0
—
—
—
—
$0
$0
Balance sheet
Cash
$16,711
$0
$0
$0
$608
$766
$433,435
$301,337
$157,589
$113,489
$13,616
Accounts receivable
$120,758
$76,109
$0
—
—
$0
$178,555
$186,285
$224,641
$160,996
$0
Total assets
$181,483
$86,038
$0
$0
$608
$766
$5,243,884
$4,800,044
$4,449,587
$651,881
$250,410
Short-term debt
$1,144,770
$818,998
$32,312
$565,733
$728,650
$0
$715,143
$180,626
$802,063
$832,773
$330,871
Long-term debt
$131,336
—
—
—
—
—
$14,466
$0
$2,036,841
—
—
Total liabilities
$2,958,729
$2,480,970
$2,100,017
$2,666,876
$3,032,828
$4,039,381
$5,299,329
$6,210,483
$5,757,973
$6,134,843
$1,303,443
Other
Headcount
—
—
—
—
—
—
—
—
31
—
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$3.5M
est. pre-money
Reg A+ · Equity · Dec 2024

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Jun 30, 2025
ClassOutstandingVotes / shareShare of totalLast price
Common Stock59,838,963—100.0%—

Shares outstanding over timein today's share terms

60M30M0
Jun 2020Jun 2025
Common StockSeries A Convertible Preferred StockSplit / conversion

Changes in named holdersshares in today's terms · % of all shares at the time

Principal holders% as the filing states it, Jan 8, 2026

  • Edward Dovner100,542 Series B Convertible Preferred Stock27.4%of Series B Convertible Preferred
  • Edward Dovner100,542 Preferred Stock27.4%of company
  • Michael Friedman13,668,607 Common Stock22.8%of
  • Edward Dovner12,548,834 Common Stock21.0%of
  • Beverly and Leonard Mezei75,141 Preferred Stock20.4%of company
  • Beverly and Leonard Mezei75,141 Series B Convertible Preferred Stock20.4%of Series B Convertible Preferred
  • Beverly and Leonard Mezei9,407,432 Common Stock15.7%of
  • Charles Everhardt50,542 Series B Convertible Preferred Stock13.8%of Series B Convertible Preferred
  • Charles Everhardt50,542 Preferred Stock13.8%of company
  • Charles Everhardt7,514,212 Common Stock12.6%of
  • Kova Trading, LLC25,400 Preferred Stock6.91%of company
  • Kova Trading, LLC25,400 Series B Convertible Preferred Stock6.91%of Series B Convertible Preferred
  • Oren Levi25,000 Preferred Stock6.8%of company
  • Chaim Narkis25,000 Series B Convertible Preferred Stock6.8%of Series B Convertible Preferred
  • Oren Levi25,000 Series B Convertible Preferred Stock6.8%of Series B Convertible Preferred
  • Chaim Narkis25,000 Preferred Stock6.8%of company
  • Kova Trading, LLC3,180,000 Common Stock5.31%of
  • Len Morales807,295 Common Stock1.35%of
  • Harold Kestenbaum100,000 Common Stock0.17%of
  • Everyone else (not named in filings)17.9%

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $0 / $2MEst. pre-money $3.5M
Raised $40KInvestors 2
Raised $1MInvestors 12

Team

3 people
Michael Friedman
Director (1)(3), CEO, President & Chief Financial Officer (2)
Charles Everhardt
Chairman of the Board (1)
Harold Kestenbaum
Director (1)(4)

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 10-KJan 8, 20260001477932-26-000103
    EDGAR
  • Form 10-QMay 20, 20250001477932-25-004040
    EDGAR
  • Form 10-QFeb 19, 20250001477932-25-001116
    EDGAR
  • Form QUALIFDec 31, 20249999999994-25-000001
    EDGAR
  • Form 1-ADec 20, 20240001477932-24-008248
    EDGAR
  • Form 10-Q/ANov 20, 20240001477932-24-007512
    EDGAR
  • Form 10-QNov 19, 20240001477932-24-007423
    EDGAR
  • Form 10-KOct 16, 20240001477932-24-006452
    EDGAR
Source: SEC EDGARCIK 0001331612DEShare price $0.125Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.